Morabito Quoted in The Wall Street Journal about Court Approval of GST AutoLeather Bankruptcy Sale
13 November 2017
Wall Street Journal
Partner Erika Morabito is quoted in a Wall Street Journal article, “GST AutoLeather Wins Court Approval of Bankruptcy Sale Process,” about an agreement between the company’s lenders and unsecured creditors on financing, fees and a process to sell the bankrupt upholstery maker’s business.
Morabito, counsel to the company’s official committee of unsecured creditors, said during a bankruptcy hearing that the lenders were holding the process “hostage” and called “insulting” a court filing by Royal Bank of Canada, part of a group of lenders, that said the unsecured creditors “should be cheering” the financing, “not objecting” to it.
Click here to read the full article (subscription required).
Morabito, counsel to the company’s official committee of unsecured creditors, said during a bankruptcy hearing that the lenders were holding the process “hostage” and called “insulting” a court filing by Royal Bank of Canada, part of a group of lenders, that said the unsecured creditors “should be cheering” the financing, “not objecting” to it.
Click here to read the full article (subscription required).
Related News
10 October 2024
In the News
Christopher King Highlights M&A Due Diligence Considerations
Foley & Lardner LLP partner Christopher King's comments on M&A due diligence at the Association of Corporate Counsel's annual meeting were highlighted in the Legal Dive article, "Can this marriage work? Legal tips for corporate M&A."
09 October 2024
In the News
Jason Mehta Weighs in on SEC Settlements, Clinical Research Fraud
Foley & Lardner LLP partner Jason Mehta commented on a recent health care litigation settlement with the U.S. Securities and Exchange Commission in the Clinical Trials Arena article, “Cassava Sciences: Phase III trials storm ahead amid controversy.”
08 October 2024
In the News
John Strom Assesses BIOSECURE ACT – 'Going to be tough to navigate'
Foley & Lardner LLP special counsel John Strom shared insight on the potential impact of the BIOSECURE ACT in the BioSpaces article, "WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow."